HomeCompareMICDX vs JNJ

MICDX vs JNJ: Dividend Comparison 2026

MICDX yields 3.94% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MICDX wins by $1657.84M in total portfolio value
10 years
MICDX
MICDX
● Live price
3.94%
Share price
$15.51
Annual div
$0.61
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1657.86M
Annual income
$1,580,697,529.21
Full MICDX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — MICDX vs JNJ

📍 MICDX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMICDXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MICDX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MICDX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MICDX
Annual income on $10K today (after 15% tax)
$334.51/yr
After 10yr DRIP, annual income (after tax)
$1,343,592,899.83/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, MICDX beats the other by $1,343,592,196.22/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MICDX + JNJ for your $10,000?

MICDX: 50%JNJ: 50%
100% JNJ50/50100% MICDX
Portfolio after 10yr
$828.94M
Annual income
$790,349,178.50/yr
Blended yield
95.34%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

MICDX
No analyst data
Altman Z
-0.7
Piotroski
4/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MICDX buys
0
JNJ buys
0
No recent congressional trades found for MICDX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMICDXJNJ
Forward yield3.94%3.36%
Annual dividend / share$0.61$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR100%5.8%
Portfolio after 10y$1657.86M$20.0K
Annual income after 10y$1,580,697,529.21$827.78
Total dividends collected$1652.33M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MICDX vs JNJ ($10,000, DRIP)

YearMICDX PortfolioMICDX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,487$787.08$10,676$355.77+$811.00MICDX
2$13,981$1,689.95$11,407$389.39+$2.6KMICDX
3$18,804$3,844.62$12,198$426.53+$6.6KMICDX
4$29,786$9,665.34$13,056$467.62+$16.7KMICDX
5$60,488$28,616.51$13,987$513.12+$46.5KMICDX
6$173,343$108,621.54$14,998$563.56+$158.3KMICDX
7$767,316$581,838.97$16,098$619.52+$751.2KMICDX
8$5,635,143$4,814,114.67$17,295$681.69+$5.62MMICDX
9$72,113,126$66,083,522.55$18,599$750.82+$72.09MMICDX
10$1,657,858,574$1,580,697,529.21$20,022$827.78+$1657.84MMICDX

MICDX vs JNJ: Complete Analysis 2026

MICDXStock

Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in dividend-paying equity securities of companies located in China. It may also invest in convertible debt and equity securities of any maturity and quality, including those that are unrated, or would be below investment grade if rated, of companies located in China. China also includes its administrative and other districts, such as Hong Kong.

Full MICDX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this MICDX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MICDX vs SCHDMICDX vs JEPIMICDX vs OMICDX vs KOMICDX vs MAINMICDX vs ABBVMICDX vs MRKMICDX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.